Characterization of Listeria monocytogenes Recovered from Imported Cheese Contributed to the National PulseNet Database by the US Food and Drug Administration from 2001 to 2008

被引:2
|
作者
Timbo, Babgaleh B. [1 ]
Keys, Christine [2 ]
Klontz, Karl [1 ]
机构
[1] US FDA, Off Food Def Commun & Emergency Response, College Pk, MD 20740 USA
[2] US FDA, Off Regulatory Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA
关键词
FIELD GEL-ELECTROPHORESIS; MEXICAN-STYLE CHEESE; PROTOCOL; OUTBREAK;
D O I
10.4315/0362-028X-73.8.1511
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Imported foods must meet the same U S Food and Drug Administration (FDA) standards as domestic foods The FDA determines whether an imported food is in compliance with the Federal Food, Drug, and Cosmetic Act. Pursuant to its regulatory activities, the FDA conducts compliance surveillance on imported foods offered for entry into the U S commerce. The National PulseNet Database is the molecular surveillance network for foodborne infections and is widely used to provide real-time subtyping support to epidemiologic investigations of foodborne diseases FDA laboratories use pulsed-field gel electrophoresis to subtype foodborne pathogens recovered from imported foods and submit the molecular patterns to the National PulseNet Database at the Centers for Disease Control and Prevention There were 60 isolates of Listeria monocytogenes in the FDA Field Accomplishment and Compliance Tracking System from 2001 to 2008 due to cheese imported from the following countries. Mexico (n = 21 isolates), Italy (19), Israel (9), Portugal (5), Colombia (3), Greece (2), and Spain (1). We observed genetic diversity of L monocytogenes isolates and genetic relatedness among strains recovered from imported cheese products coming to the United States from different countries. Consistent characterization of L monocytogenes isolates recovered from imported cheeses, accompanied by epidemiologic investigations to ascertain human illness associated with these strains, could be helpful in the control of listeriosis acquired from imported cheeses.
引用
收藏
页码:1511 / 1514
页数:4
相关论文
共 30 条
  • [21] Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study
    Phan, Michael
    Cheng, Carmen
    Dang, Vivian
    Wu, Eileen
    Munoz, Monica A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (05) : 1062 - 1073
  • [22] Use of US Food and Drug Administration expedited drug development and review programs by orphan and nonorphan novel drugs approved from 2008 to 2021 (vol 5, e2239336, 2022)
    Monge, A. N.
    Sigelman, D. W.
    Temple, R. J.
    Chahal, H. S.
    JAMA NETWORK OPEN, 2023, 6 (02)
  • [23] Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
    Mazhar, Faizan
    Battini, Vera
    Pozzi, Marco
    Invernizzi, Elena
    Mosini, Giulia
    Gringeri, Michele
    Capuano, Annalisa
    Scavone, Cristina
    Radice, Sonia
    Clementi, Emilio
    Carnovale, Carla
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (06): : 477 - 489
  • [24] Inadequate and delayed characterization of cutaneous reactions for US Food and Drug Administration-approved oncologic drugs from 2011-2020 leading to medication discontinuation
    Yang, Jason J.
    So, Naomi
    Maloney, Nolan J.
    Arzeno, Julia
    Clifton, Katherine K.
    Bach, Daniel Q.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (05) : 1351 - 1352
  • [25] Interaction between cannabis and cytochromes P450 substrates: Potential safety signals from a disproportionality analysis using the US food and drug administration adverse event reporting system database
    Li, Xiaotong
    Chapin, Maryann
    Kane-Gill, Sandra L.
    Boyce, Richard D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 476 - 476
  • [26] Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
    Mooghali, Maryam
    Ross, Joseph S.
    Kadakia, Kushal
    Dhruva, Sanket S.
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2023, 16 : 111 - 122
  • [27] Fifteen-Year Trend in Inferior Vena Cava Filter Utilization before and after US Food and Drug Administration Communications: Data from the National Inpatient Sample 2005-2019
    Yoo, Junhwi
    Ahmed, Osman
    Chadalavada, Seetharam
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2024, 35 (09)
  • [28] CHARACTERIZATION OF SAFETY EVENTS FOR ENERGY-BASED DEVICES FOR TREATMENT OF VAGINAL SYMPTOMS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE (MAUDE) DATABASE FROM 2013 TO 2016
    Wallace, Shannon
    Enemchukwu, Ekene
    JOURNAL OF UROLOGY, 2019, 201 (04): : E660 - E661
  • [29] Comparison of technical failures and patient-related adverse events associated with 3 widely used mechanical lithotripters for ERCP: insights from the US Food and Drug Administration Manufacturer and User Facility Device Experience database
    Kucharski, Kim
    Adler, Douglas G.
    GASTROINTESTINAL ENDOSCOPY, 2022, 96 (05) : 796 - 800
  • [30] Change in Use of Gadolinium-Enhanced Magnetic Resonance Studies in Kidney Disease Patients After US Food and Drug Administration Warnings: A Cross-sectional Study of Veterans Affairs Health Care System Data From 2005-2008
    Kim, Kyung-Ho
    Fonda, Jennifer R.
    Lawler, Elizabeth V.
    Gagnon, David
    Kaufman, James S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (03) : 458 - 467